Ngày 6/4, Công ty dược phẩm Inovio Pharmaceuticals thông báo Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) đã chấp nhận đơn đăng ký dược phẩm nghiên cứu mới (IND) của công ty này đối với INO-4800 - một ứng cử viên vắc-xin được chế tạo để chống lại sự lây nhiễm của COVID-19.

Tin liên quan

Đọc nhiều

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

Theo dangcongsan.vn

 {name} - {time}

 Trả lời

{body}
 {name} - {time}
{body}

0 bình luận

Ý kiến của bạn sẽ được biên tập trước khi đăng. Vui lòng gõ tiếng Việt có dấu
Chia sẻ thông tin với bạn bè!
Tắt [X]